Ngày 6/4, Công ty dược phẩm Inovio Pharmaceuticals thông báo Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) đã chấp nhận đơn đăng ký dược phẩm nghiên cứu mới (IND) của công ty này đối với INO-4800 - một ứng cử viên vắc-xin được chế tạo để chống lại sự lây nhiễm của COVID-19.

Tin liên quan

Đọc nhiều

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

Theo dangcongsan.vn

 {name} - {time}

 Trả lời

{body}
 {name} - {time}
{body}

0 bình luận

Ý kiến của bạn sẽ được biên tập trước khi đăng. Vui lòng gõ tiếng Việt có dấu
Chia sẻ thông tin với bạn bè!
Tắt [X]